12.08.22
The US Food and Drug Administration (FDA) has released the results of the its 2022 sampling assignment, testing talc-containing cosmetic products for the presence of asbestos. Asbestos was not detected in any of the 50 samples tested in 2022. The testing was conducted using polarized light microscopy (PLM) and transmission electron microscopy (TEM).
The summary results can be found here. Similar results were revealed in 2021.
Products were selected and purchased by the FDA, and then samples of the products were blinded and transferred to AMA for analysis. The products were selected based on various factors including type of talc-containing cosmetic product, price range, popular products on social media and in advertisements, products marketed to children, products marketed to women of color, and, if any, third party reports of potential asbestos contamination.
In the coming year, the FDA plans to issue draft guidance for testing asbestos in talc-containing cosmetic products.
The summary results can be found here. Similar results were revealed in 2021.
Products were selected and purchased by the FDA, and then samples of the products were blinded and transferred to AMA for analysis. The products were selected based on various factors including type of talc-containing cosmetic product, price range, popular products on social media and in advertisements, products marketed to children, products marketed to women of color, and, if any, third party reports of potential asbestos contamination.
In the coming year, the FDA plans to issue draft guidance for testing asbestos in talc-containing cosmetic products.